Elutia Inc (ELUT) - News Archive

Elutia Inc. Sees Revenue Growth Amidst Industry Challenges, Highlighted by Positive Clinical Data for Biologic Envelopes In recent announcements, Elutia Inc. has showcased promising developments in both clinical data an...

In a significant update from Silver Spring, Maryland, Elutia Inc. (Nasdaq: ELUT), a prominent innovator in the realm of drug-eluting biomatrix products, has confirmed that the ongoing global tariff environment has not m...

Groundbreaking Study Confirms the Efficacy of Elutia s Antibiotic-Eluting BioEnvelope, EluPro, in Preventing Cardiac Device Infections Elutia Inc. a leader in the development of advanced medical devices, has recently un...

Elutia Inc. Begins a New Era in Cardiac and Neurostimulation Treatment with EluPro BioEnvelope By Elutia Inc. (Nasdaq: ELUT) has announced a significant milestone in the field of cardiac and neurostimulation therapy wit...

Elutia Inc: Struggles and Successes in the Drug Discovery IndustryThe drug discovery industry is a complex field that requires extensive research, testing, and regulatory approval before a new medication can reach the m...

Elutia Inc. Raises Funds through Registered Direct Offering to Fuel GrowthSilver Spring-based company, Elutia Inc., recently announced a registered direct offering that is set to raise approximately $13.26 million for t...

Elutia, a foremost innovator in the field of cardiac medical devices, has marked a historic milestone with the FDA clearance of its latest advancement, EluPro. This pioneering product, touted as the first antibiotic-elu...